Capstone Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8M Buy
18,300
+9,900
+118% +$10M 0.03% 204
2025
Q4
$9.03M Sell
8,400
-8,300
-50% -$7.94M 0.02% 282
2025
Q3
$12.7M Buy
16,700
+6,200
+59% +$4.61M 0.02% 276
2025
Q2
$8.19M Sell
10,500
-9,500
-48% -$7.38M 0.02% 295
2025
Q1
$16.5M Sell
20,000
-26,000
-57% -$21.6M 0.04% 206
2024
Q4
$35.5M Buy
46,000
+14,300
+45% +$11.8M 0.09% 136
2024
Q3
$28.1M Buy
31,700
+300
+1% +$270K 0.09% 137
2024
Q2
$28.4M Buy
31,400
+4,600
+17% +$3.68M 0.09% 145
2024
Q1
$20.8M Sell
26,800
-23,500
-47% -$16.7M 0.08% 167
2023
Q4
$29.3M Buy
50,300
+15,900
+46% +$9.28M 0.09% 159
2023
Q3
$18.5M Buy
34,400
+2,900
+9% +$1.49M 0.08% 160
2023
Q2
$14.8M Buy
31,500
+4,100
+15% +$1.72M 0.07% 186
2023
Q1
$9.41M Sell
27,400
-26,300
-49% -$8.87M 0.05% 253
2022
Q4
$19.6M Buy
53,700
+1,100
+2% +$390K 0.14% 108
2022
Q3
$17M Buy
52,600
+7,300
+16% +$2.31M 0.1% 128
2022
Q2
$14.7M Sell
45,300
-46,200
-50% -$13.9M 0.07% 180
2022
Q1
$26.2M Sell
91,500
-2,800
-3% -$721K 0.07% 208
2021
Q4
$26M Sell
94,300
-31,000
-25% -$7.86M 0.04% 363
2021
Q3
$29M Sell
125,300
-4,200
-3% -$1.04M 0.06% 317
2021
Q2
$29.7M Sell
129,500
-21,400
-14% -$4.3M 0.07% 264
2021
Q1
$28.2M Buy
150,900
+64,400
+74% +$12.6M 0.08% 218
2020
Q4
$14.6M Buy
86,500
+20,800
+32% +$3.11M 0.05% 309
2020
Q3
$9.72M Buy
65,700
+26,100
+66% +$4.04M 0.05% 334
2020
Q2
$6.5M Sell
39,600
-10,700
-21% -$1.64M 0.04% 354
2020
Q1
$6.98M Sell
50,300
-54,600
-52% -$7.5M 0.11% 199
2019
Q4
$13.8M Buy
104,900
+21,800
+26% +$2.53M 0.07% 276
2019
Q3
$9.29M Buy
83,100
+24,700
+42% +$2.75M 0.06% 298
2019
Q2
$6.47M Sell
58,400
-2,000
-3% -$236K 0.05% 395
2019
Q1
$7.84M Sell
60,400
-30,500
-34% -$3.71M 0.07% 263
2018
Q4
$10.5M Buy
90,900
+8,700
+11% +$972K 0.13% 129
2018
Q3
$8.82M Buy
+82,200
New +$8.22M 0.1% 166
2017
Q2
Sell
-5,600
Closed -$471K 799
2017
Q1
$471K Sell
5,600
-2,100
-27% -$168K 0.01% 614
2016
Q4
$563K Buy
+7,700
New +$573K 0.02% 559
2014
Q1
Sell
-28,200
Closed -$1.44M 467
2013
Q4
$1.44M Buy
+28,200
New +$1.41M 0.02% 374

Other funds holding LLY

Capstone Investment Advisors's LLY Position: Q1 2026 in Review

Capstone Investment Advisors increased its Eli Lilly (LLY) stake by 275% in Q1 2026, buying an estimated $3.8M and bringing the position to 5,107 shares worth $4.7M. The position accounts for 0.01% of the portfolio, ranked #433.

Capstone Investment Advisors first reported a position in LLY in Q3 2013 and has held it in 28 quarters since. The position peaked at $19.5M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capstone Investment Advisors held 5,107 shares of Eli Lilly worth $4.7M as of Q1 2026.
  • Capstone Investment Advisors bought 3,746 Eli Lilly shares in Q1 2026, an estimated $3.8M.
  • Eli Lilly made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #433 holding.
  • Capstone Investment Advisors first reported a position in Eli Lilly in Q3 2013 and has held it in 28 quarters since.
  • Capstone Investment Advisors's Eli Lilly position peaked at $19.5M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.